Author:
Narvekar Aditya,Srivastav Ashu,Tripathi Aparna,Devarajan Padma V.,Jain Ratnesh,Dandekar Prajakta
Publisher
Springer International Publishing
Reference66 articles.
1. Insel PA, Sriram K, Wiley SZ, French RP, Lowy AM. GPCRs as novel potential therapeutic targets in cancer. FASEB J. 2017;31(1_supplement):671.10.
2. Zalewska M, Siara M, Sajewicz W. G protein-coupled receptors: abnormalities in signal transmission, disease states and pharmacotherapy. Acta Pol Pharm. 2014;71(2):229–43.
3. Hauser AS, Chavali S, Masuho I, Jahn LJ, Martemyanov KA, Gloriam DE, et al. Pharmacogenomics of GPCR drug targets. Cell. 2018;172(1–2):41–54. e19.
4. Pierce KL, Premont RT, Lefkowitz RJ. Signalling: seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3(9):639.
5. DeFea K, Vaughn Z, O’bryan E, Nishijima D, Dery O, Bunnett N. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc Natl Acad Sci. 2000;97(20):11086–91.